BOSTON (Standard&Poor's) Oct. 5, 2015—Standard&Poor's Ratings Services today assigned its 'A-1' short-term rating to AbbVie Inc.'s $2 billion senior unsecured 364-day term loan and 'A' long-term rating to the company's $2 billion senior unsecured term loan due 2018. Proceeds will not affect our leverage calculation since the company will redeem existing unsecured debt that matures over the next few months. Our 'A' corporate credit rating on AbbVie Inc. reflects its well-established position in the branded pharmaceuticals market, offset by pro forma leverage in excess of 2x that we expect to improve over the next two years. AbbVie's highly profitable market-leading products and a promising pipeline over the next three years support our assessment of a "strong"
